or Try an Advanced Search...

    Technical Analysis for BCDA - BioCardia, Inc.

    Grade Last Price % Change Price Change
    F 0.40 -0.45% 0.00
    BCDA closed up 0.98 percent on Wednesday, May 15, 2024, on 35 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical BCDA trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish -0.45%
    NR7 Range Contraction -0.45%
    Narrow Range Bar Range Contraction -0.45%
    Earnings Movers Other -0.45%
    Gapped Down Weakness -0.45%
    20 DMA Support Bullish 0.53%
    Crossed Above 50 DMA Bullish 0.53%
    MACD Bullish Centerline Cross Bullish 0.53%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.53%
    Earnings Movers Other 0.53%
    Older End-of-Day Signals for BCDA ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 31 minutes ago
    Upper Bollinger Band Resistance about 2 hours ago
    Rose Above Upper Bollinger Band about 2 hours ago
    2x Volume Pace about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BCDA Chart by TradingView
    Basic chart:

    Profile

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Vascular Access Products Bone Marrow Aging Associated Diseases Ischemia Treatment Of Heart Failure

    Is BCDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
    May 15 BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
    May 14 BioCardia GAAP EPS of -$0.09, revenue of $0.05M
    May 14 BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
    May 14 Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
    May 9 BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
    May 1 BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
    Apr 25 BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
    Apr 2 Insiders Are Buying These 11 Penny Stocks
    Apr 1 BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
    See more BCDA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.9199
    52 Week Low 0.32
    Average Volume 257,108
    200-Day Moving Average 0.52
    50-Day Moving Average 0.39
    20-Day Moving Average 0.38
    10-Day Moving Average 0.39
    Average True Range 0.02
    RSI (14) 56.33
    ADX 13.55
    +DI 19.43
    -DI 14.33
    Chandelier Exit (Long, 3 ATRs) 0.35
    Chandelier Exit (Short, 3 ATRs) 0.38
    Upper Bollinger Bands 0.40
    Lower Bollinger Band 0.36
    Percent B (%b) 0.9
    BandWidth 11.78
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram 0.0037
    Fundamentals Value
    Market Cap 9.45 Million
    Num Shares 23.6 Million
    EPS -0.62
    Price-to-Earnings (P/E) Ratio -0.65
    Price-to-Sales 17.62
    Price-to-Book 10.67
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.41
    Resistance 3 (R3) 0.41 0.41 0.41
    Resistance 2 (R2) 0.41 0.40 0.41 0.41
    Resistance 1 (R1) 0.40 0.40 0.40 0.40 0.41
    Pivot Point 0.40 0.40 0.40 0.40 0.40
    Support 1 (S1) 0.39 0.39 0.40 0.40 0.39
    Support 2 (S2) 0.39 0.39 0.39 0.39
    Support 3 (S3) 0.38 0.39 0.39
    Support 4 (S4) 0.39